Rezultati - Andreas H. Scheel
- Showing 1 - 20 results of 26
- Go to Next Page
-
1
-
2
-
3
Impact of updated HER2 testing guidelines in breast cancer—re-evaluation of HERA trial fluorescence in situ hybridization data od Oliver Stoß, Andreas H. Scheel, Iris Nagelmeier, Hans‐Ulrich Schildhaus, Thomas Henkel, Giuseppe Viale, Bharat Jasani, Michael Untch, Josef Rüschoff
Izdano 2015Artigo -
4
-
5
-
6
-
7
p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis od Flaminia Talos, A Abraham, Angelina V. Vaseva, Lena Holembowski, Stella E. Tsirka, Andreas H. Scheel, Daniel Bode, Matthias Dobbelstein, Wolfgang Brück, Ute M. Moll
Izdano 2010Artigo -
8
-
9
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC od Christoph Arolt, Margaret Dugan, Robert Wild, Vanessa Richartz, Barbara Holz, Andreas H. Scheel, Johannes Brägelmann, Svenja Wagener‐Ryczek, Sabine Merkelbach‐Bruse, Juergen Wolf, Reinhard Buettner, Luigi Catanzariti, Matthias Scheffler, Axel M. Hillmer
Izdano 2023Artigo -
10
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas od Andreas H. Scheel, Manfred Dietel, Lukas C. Heukamp, Korinna Jöhrens, Thomas Kirchner, Simone Reu, Josef Rüschoff, Hans‐Ulrich Schildhaus, Peter Schirmacher, Markus Tiemann, Arne Warth, Wilko Weichert, Rieke Fischer, Jürgen Wolf, Reinhard Buettner
Izdano 2016Artigo -
11
Genetic instability and recurrent <i>MYC</i> amplification in <i>ALK‐</i>translocated NSCLC: a central role of <i>TP53</i> mutations od Christina Alidousty, Till Baar, Luciano G. Martelotto, Carina Heydt, Svenja Wagener, Jana Fassunke, Nicolai Duerbaum, Andreas H. Scheel, Sandra Frank, Barbara Holz, Elke Binot, Anna Kron, Sabine Merkelbach‐Bruse, Michaela A. Ihle, Jürgen Wolf, Reinhard Buettner, Anne M. Schultheis
Izdano 2018Artigo -
12
Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast Cancer od Josef Rüschoff, Alexander Penner, Ian O. Ellis, M. Elizabeth Hammond, Annette Lebeau, R. Yoshiyuki Osamura, Frédérique Penault‐Llorca, Federico Rojo, Chirag S. Desai, Akira Moh, Neil Atkey, Gudrun Baenfer, Andreas H. Scheel, Corrado D’Arrigo, Hans‐Ulrich Schildhaus, Giuseppe Viale
Izdano 2024Artigo -
13
PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations od Andreas H. Scheel, Sascha Ansén, Anne M. Schultheis, Matthias Scheffler, Rieke Fischer, Sebastian Michels, Martin Hellmich, Julie George, Thomas Zander, Michael Brockmann, Erich Stoelben, Harry J.M. Groen, Wim Timens, Sven Perner, Michael von Bergwelt‐Baildon, Reinhard Büttner, Jürgen Wolf
Izdano 2016Artigo -
14
Genomic Amplification of <i>CD274</i> (PD-L1) in Small-Cell Lung Cancer od Julie George, Motonobu Saito, Koji Tsuta, Reika Iwakawa, Kouya Shiraishi, Andreas H. Scheel, Shinsuke Uchida, Shun‐ichi Watanabe, Ryo Nishikawa, Masayuki Noguchi, Martin Peifer, Se Jin Jang, Iver Petersen, Reinhard Büttner, Curtis C. Harris, Jun Yokota, Roman K. Thomas, Takashi Kohno
Izdano 2016Artigo -
15
Interlaboratory concordance of <scp>PD</scp>‐L1 immunohistochemistry for non‐small‐cell lung cancer od Andreas H. Scheel, Gudrun Baenfer, Gustavo Baretton, Manfred Dietel, Rolf Diezko, Thomas Henkel, Lukas C. Heukamp, Bharat Jasani, Korinna Jöhrens, Thomas Kirchner, Felix Lasitschka, Iver Petersen, Simone Reu, Hans‐Ulrich Schildhaus, Peter Schirmacher, Kristina Schwamborn, Ulrich Sommer, Oliver Stoß, Markus Tiemann, Arne Warth, Wilko Weichert, Jürgen Wolf, Reinhard Büttner, Josef Rüschoff
Izdano 2017Artigo -
16
Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients od Dennis Plenker, Miriam Bertrand, Adrianus J. de Langen, Richard Riedel, Carina Lorenz, Andreas H. Scheel, Judith Müller, Johannes Brägelmann, Juliane Daßler‐Plenker, Carsten Kobe, Thorsten Persigehl, Alexander Kluge, Thomas Würdinger, Pepijn Schellen, Gunther Hartmann, Tobias Zacherle, Roopika Menon, Erik Thunnissen, Reinhard Büttner, Frank Griesinger, Jürgen Wolf, Lukas C. Heukamp, Martin L. Sos, Johannes M. Heuckmann
Izdano 2017Artigo -
17
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF od Mariangela Di Tacchio, Jadranka Macas, Jakob Weissenberger, Kathleen Sommer, Oliver Bähr, Jörg Steinbach, Christian Senft, Volker Seifert, Martin Glas, Ulrich Herrlinger, Dietmar Krex, Matthias Meinhardt, Astrid Weyerbrock, Marco Timmer, Roland Goldbrunner, Martina Deckert, Andreas H. Scheel, Reinhard Büttner, Oliver Grauer, Jens Schittenhelm, Ghazaleh Tabatabai, Patrick N. Harter, Stefan Günther, Kavi Devraj, Karl H. Plate, Yvonne Reiss
Izdano 2019Artigo -
18
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy od Emina Torlakovic, Hyun J. Lim, Julien Adam, Penny J. Barnes, Gilbert Bigras, Anthony W.H. Chan, Carol C. Cheung, Jin-Haeng Chung, Christian Couture, Pierre Fiset, Daichi Fujimoto, Gang Han, Fred R. Hirsch, Marius Ilié, Diana N. Ionescu, Chao Li, Enrico Munari, Katsuhiro Okuda, M. Ratcliffe, David L. Rimm, Catherine Ross, Rasmus Røge, Andreas H. Scheel, Ross A. Soo, Paul E. Swanson, Maria Tretiakova, Ka‐Fai To, Gilad W. Vainer, Hangjun Wang, Zhaolin Xu, Dirk Zielinski, Ming‐Sound Tsao
Izdano 2019Revisão -
19
B-cell–specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice od Gero Knittel, Paul Liedgens, Darya Korovkina, Jens M. Seeger, Yussor Al-Baldawi, Mona Al-Maarri, Christian Fritz, Katerina Vlantis, S. D. Bezhanova, Andreas H. Scheel, Olaf‐Oliver Wolz, Maurice Reimann, Peter Möller, Cristina López, Matthias Schlesner, Philipp Lohneis, Alexander N.R. Weber, Lorenz Trümper, Louis M. Staudt, Monika Ortmann, Manolis Pasparakis, Reiner Siebert, Clemens A. Schmitt, Andreas R. Klatt, F. Thomas Wunderlich, Stephan Schäfer, Thorsten Persigehl, Manuel Montesinos‐Rongen, Margarete Odenthal, Reinhard Büttner, Lukas P. Frenzel, Hamid Kashkar, Hans Christian Reinhardt
Izdano 2016Artigo -
20
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors od Dennis Plenker, M Riedel, Johannes Brägelmann, Marcel A. Dammert, Rakhee Chauhan, Phillip P. Knowles, Carina Lorenz, Marina Keul, Mike Bührmann, Oliver Pagel, Verena Tischler, Andreas H. Scheel, Daniel Schütte, Yanrui Song, Justina Stark, Florian Mrugalla, Yannic Alber, André Richters, Julian Engel, Frauke Leenders, Johannes M. Heuckmann, Jürgen Wolf, Joachim Diebold, Georg Pall, Martin Peifer, Maarten Aerts, Kris Gevaert, René P. Zahedi, Reinhard Buettner, Kevan M. Shokat, Neil Q. McDonald, Stefan M. Kast, Oliver Gautschi, Roman K. Thomas, Martin L. Sos
Izdano 2017Artigo
Iskalna orodja:
Sorodne teme
Medicine
Biology
Cancer
Cancer research
Genetics
Gene
Internal medicine
Oncology
Lung cancer
Pathology
Mutation
Biochemistry
Immunohistochemistry
Immunotherapy
Adenocarcinoma
Chemistry
Immunology
Antibody
PD-L1
Breast cancer
Carcinoma
Chromosome
Concordance
EGFR inhibitors
Epidermal growth factor receptor
Fluorescence in situ hybridization
Immune system
KRAS
Malignant pleural effusion
Mutant